PT-141 10MG

PT-141, also known as Bremelanotide, is a cyclic melanocortin-receptor agonist research peptide studied for its effects on central nervous system and neuroendocrine signalling. Unlike compounds acting primarily through peripheral vascular pathways, PT-141 provides a receptor-focused model for investigating melanocortin-mediated behavioural responses.

Laboratory research examines PT-141 in relation to MC3R and MC4R activity, neural signalling, hormonal feedback and behavioural-response pathways. The 10 mg format supports controlled comparative studies.

Choice Peptides PT-141 10 mg is supplied in a format selected for accurate measurement and consistent laboratory handling.

Form: Lyophilized peptide powder
Contents: 10 mg per vial
Purity: ≥99%
Testing: Meticulously tested for identity, quality and consistency
Storage: Keep in a cool, dry environment; refrigerate at 2°C–8°C after reconstitution.
Intended use: For laboratory research purposes only. Not for human or veterinary use.